Literature DB >> 34079268

Tuberculosis Relapse in the Epididymis After the Completion of Nine Months of Anti-Tuberculosis Chemotherapy in a Patient with Poorly Controlled Diabetes Mellitus.

Chikako Ichikawa1, Sho Tanaka2,3, Masahiro Takubo1,3, Masaru Kushimoto3, Jin Ikeda3, Katsuhiko Ogawa3,4, Ichiro Tsujino3,5, Yutaka Suzuki3,4, Masanori Abe2, Hisamitsu Ishihara1, Midori Fujishiro1,3.   

Abstract

The standard six-month tuberculosis (TB) treatment comprises an intensive phase lasting two months, followed by a continuation phase lasting four months. Meanwhile, the nine-month regimen, which has a prolonged continuation phase, is indicated for patients with complicated diabetes mellitus (DM) because of their poor response to treatment. A 61-year-old Japanese man with poorly controlled DM for five years presented with bilateral scrotal swelling noticed two weeks ago. He had a history of pleuritis, pericarditis, and peritonitis two years ago. These symptoms led to the diagnosis of culture-negative extrapulmonary TB. He received the nine-month chemotherapy regimen (isoniazid, rifampin, pyrazinamide, and ethambutol for two months, followed by isoniazid and rifampin for seven months), and his symptoms significantly improved. The swollen scrotum was accompanied by mild tenderness and pus discharge from a fistula. Imaging study revealed bilaterally diffusely enlarged epididymis. However, the acid-fast bacilli smear and culture and polymerase chain reaction using urine and pus discharge tested negative. Bilateral epididymectomy was performed. Although the acid-fast bacilli smear was negative, the pathology demonstrated granuloma formation and acid-fast bacilli tissue culture confirmed multi-drug resistant Mycobacterium tuberculosis. The optimal treatment regimen and duration for extrapulmonary TB with unknown drug susceptibility are debatable. The nine-month regimen can be insufficient in some cases. Thus, detailed follow-up is essential, and TB relapse should be thoroughly monitored.
© 2021 Ichikawa et al.

Entities:  

Keywords:  chemotherapy; diabetes mellitus; epididymitis; tuberculosis

Year:  2021        PMID: 34079268      PMCID: PMC8164866          DOI: 10.2147/TCRM.S310463

Source DB:  PubMed          Journal:  Ther Clin Risk Manag        ISSN: 1176-6336            Impact factor:   2.423


  24 in total

1.  Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes.

Authors:  Hanneke M J Nijland; Rovina Ruslami; Janneke E Stalenhoef; Erni J Nelwan; Bachti Alisjahbana; Ron H H Nelwan; Andre J A M van der Ven; Halim Danusantoso; Rob E Aarnoutse; Reinout van Crevel
Journal:  Clin Infect Dis       Date:  2006-08-22       Impact factor: 9.079

2.  Optimal duration of anti-TB treatment in patients with diabetes: nine or six months?

Authors:  Jann-Yuan Wang; Ming-Chia Lee; Chin-Chung Shu; Chih-Hsin Lee; Li-Na Lee; Kun-Mao Chao; Feng-Yee Chang
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

3.  Genitourinary tuberculosis: review of 102 cases.

Authors:  W I Christensen
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

4.  Male genital tuberculosis in Siberians.

Authors:  Ekaterina Kulchavenya; Victor Khomyakov
Journal:  World J Urol       Date:  2006-01-21       Impact factor: 4.226

5.  Scrotal tuberculosis in adult patients: a 10-year clinical experience.

Authors:  Ing-Kit Lee; Wen-Chou Yang; Jien-Wei Liu
Journal:  Am J Trop Med Hyg       Date:  2007-10       Impact factor: 2.345

6.  Urogenital tuberculosis: update and review of 8961 cases from the world literature.

Authors:  André A Figueiredo; Antônio M Lucon
Journal:  Rev Urol       Date:  2008

7.  Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.

Authors:  Aylin Babalik; Ismail Hakki Ulus; Nadi Bakirci; Tulin Kuyucu; Huseyin Arpag; Lale Dagyildizi; Esen Capaner
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

8.  The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet Infect Dis       Date:  2017-12-07       Impact factor: 71.421

9.  Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis.

Authors:  Balewgizie Sileshi Tegegne; Melkamu Merid Mengesha; Andreas A Teferra; Mamaru Ayenew Awoke; Tesfa Dejenie Habtewold
Journal:  Syst Rev       Date:  2018-10-15

10.  Risk factors for tuberculosis.

Authors:  Padmanesan Narasimhan; James Wood; Chandini Raina Macintyre; Dilip Mathai
Journal:  Pulm Med       Date:  2013-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.